Skip to main content
Open access
RESEARCH ARTICLES
Published Online: 19 May 2021

First‐Dose Methylphenidate‐Induced Changes in the Anti‐Saccade Task Performance and Outcome in Adults with Attention‐Deficit/Hyperactivity Disorder

Publication: Psychiatric Research and Clinical Practice

Abstract

Objective

We examined whether the anti‐saccade task (AST) performance after the first methylphenidate (MPH) dose could be associated with subsequent clinical outcome in adults with attention‐deficit/hyperactivity disorder (ADHD).

Methods

Ninety‐seven drug‐naive DSM‐5 ADHD adults participated in this study. The AST parameters were measured at baseline, after the first MPH‐dose (10 mg orally), and 6 months after chronic MPH treatment. Results were compared with those of 50 healthy control (HC) subjects.

Results

At baseline, ADHDs showed longer saccadic reaction times and more direction errors than HCs (both p < 0.00001). Acute and chronic MPH administration resulted in normalization of the AST performances. Multivariate regression analysis after adjusting for age, sex, weight, and severity of symptoms at baseline, revealed that a low percentage of direction errors after the first MPH‐dose (i.e., ≤10%) could predict remission at month 6 (OR: 5.84; 95% CI: 2.00–17.11; p = 0.001).

Conclusions

Our findings indicate that: (1) impairments of motor planning and response inhibition in adults with ADHD are improved with MPH, and (2) a low direction error percentage after the first MPH‐dose may be an independent predictor of remission.
ClinicalTrials.gov identifier: NCT03411434

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to Psychiatric Research and Clinical Practice
Psychiatric Research and Clinical Practice
Pages: 146 - 152

History

Received: 23 February 2021
Revision received: 27 April 2021
Accepted: 30 April 2021
Published online: 19 May 2021
Published in print: Winter 2021

Authors

Details

Fabrice Duval, M.D.
Pôle 8/9 Psychiatry, APF2R, Centre Hospitalier, Rouffach, France (F. Duval, A. Erb, M. Mokrani, T. Weiss, R. Carcangiu)
Alexis Erb, M.D.
Pôle 8/9 Psychiatry, APF2R, Centre Hospitalier, Rouffach, France (F. Duval, A. Erb, M. Mokrani, T. Weiss, R. Carcangiu)
Marie‐Claude Mokrani, Ph.D.
Pôle 8/9 Psychiatry, APF2R, Centre Hospitalier, Rouffach, France (F. Duval, A. Erb, M. Mokrani, T. Weiss, R. Carcangiu)
Thomas Weiss, M.D.
Pôle 8/9 Psychiatry, APF2R, Centre Hospitalier, Rouffach, France (F. Duval, A. Erb, M. Mokrani, T. Weiss, R. Carcangiu)
Roberta Carcangiu, M.D.
Pôle 8/9 Psychiatry, APF2R, Centre Hospitalier, Rouffach, France (F. Duval, A. Erb, M. Mokrani, T. Weiss, R. Carcangiu)

Notes

Correspondence
Dr. Duval ([email protected])

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share